氟哌啶醇癸酸酯治疗难治性精神分裂症34例临床分析  

Haloperidol Deeanoate for the Treatment Refractory Schizophrenia: A Clinical Study of 34 Cases

作　　者：李奕[1] 

机构地区：[1]成都市精神卫生中心,四川成都610036

出　　处：《成都医药》2000年第1期11-12,共2页

摘　　要：目的:了解氟哌啶醇癸酸酯治疗难治性精神分裂症疗效。方法:34例均符合DSM-Ⅲ-R中难治性精神分裂症停用其它抗精神病药物后1周,给予氟哌啶醇癸酸酯50～150mg/月,疗程16周至48周,治疗前后测定BPRS量表一次。结果:氟哌啶醇癸酸酯治疗难治性精神分裂症其显效率52.9％,有效率85.3％。结论:氟哌啶醇癸酸酯对难治性精神分裂症有效,副作用比较轻微。Purpose: This study was to examine the effect of refractory schizophrenia treated with Haloperidol Deeanoate. Method: Thirty - four refractory schizophrenia patients who met the criteria of DSM - Ⅲ- R, Were discontinue other ami - schizophrenia drugs, one week, then were treated with Haloperidol Deeanoate (does: 50-150mg/month) for 16-48 weeks. Both before and after treament, these Patients Were Searched With BPRS qnestionaire. Results: Significant effective rate is 52. 9 % , and general effective rate is 85. 3 % . The most side reaction is the ex-trapyramidal syndrome (EPS).

关 键 词：氟哌啶醇癸酸酯 精神分裂症 疗效 药物疗法 病例分析 抗精神病药 

分 类 号：R749.305[医药卫生—神经病学与精神病学] R971.4[医药卫生—临床医学]